Get the Stockscreener App
1.715
2.69%
0.045
Geron Corp stock is traded at $1.715, with a volume of 1.83M.
It is up +2.69% in the last 24 hours and up +8.54% over the past month.
Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with transfusion-dependent anemia. RYTELO inhibits telomerase activity in malignant stem and progenitor cells, which may reduce abnormal cell proliferation while supporting the production of healthy cells. It is also conducting a Phase 3 trial of imetelstat in patients with JAK-inhibitor-refractory or relapsed myelofibrosis (R/R MF) and studies in other hematologic malignancies. The company operates as a single segment, being the development of therapeutic products for oncology.
See More
Previous Close:
$1.67
Open:
$1.66
24h Volume:
1.83M
Relative Volume:
0.11
Market Cap:
$1.10B
Revenue:
$183.88M
Net Income/Loss:
$-85.78M
P/E Ratio:
-13.33
EPS:
-0.1287
Net Cash Flow:
$-110.95M
1W Performance:
-2.00%
1M Performance:
+8.54%
6M Performance:
+35.04%
1Y Performance:
+24.28%
1-Day Range:
$1.65
$1.73
1-Week Range:
$1.65
$1.8399
52-Week Range:
$1.04
$2.01
Geron Corp Stock (GERN) Company Profile
Name
Geron Corp
Sector
Industry
Phone
(650) 473-7700
Address
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Compare GERN vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.715 | 1.07B | 183.88M | -85.78M | -110.95M | -0.1287 |
VRTX
Vertex Pharmaceuticals Inc
|
442.95 | 110.97B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
754.00 | 79.17B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
804.15 | 49.73B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
325.41 | 42.98B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
308.58 | 34.37B | 5.36B | 287.73M | 924.18M | 2.5229 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Resumed | Goldman | Sell |
| May-08-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Feb-27-25 | Downgrade | B. Riley Securities | Buy → Neutral |
| Feb-26-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-05-24 | Initiated | H.C. Wainwright | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-09-24 | Initiated | Leerink Partners | Outperform |
| Apr-30-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-29-24 | Initiated | TD Cowen | Buy |
| Mar-15-24 | Reiterated | Needham | Buy |
| Sep-12-23 | Upgrade | Goldman | Neutral → Buy |
| Mar-28-23 | Initiated | Goldman | Neutral |
| Oct-28-22 | Initiated | Wedbush | Outperform |
| Jul-28-22 | Resumed | B. Riley Securities | Buy |
| Nov-02-21 | Initiated | Robert W. Baird | Outperform |
| Feb-18-21 | Resumed | B. Riley Securities | Buy |
| Aug-03-20 | Initiated | Stifel | Buy |
| Nov-19-19 | Resumed | B. Riley FBR | Buy |
| Sep-03-19 | Initiated | H.C. Wainwright | Buy |
| Aug-15-19 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-09-19 | Upgrade | Needham | Hold → Buy |
| Jan-31-19 | Upgrade | B. Riley FBR | Neutral → Buy |
| Oct-02-18 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jul-05-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Sep-13-16 | Reiterated | FBR & Co. | Outperform |
| Sep-13-16 | Reiterated | FBR Capital | Outperform |
| Dec-07-15 | Reiterated | Piper Jaffray | Overweight |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Jun-12-14 | Upgrade | MLV & Co | Hold → Buy |
| Mar-12-14 | Downgrade | MLV & Co | Buy → Hold |
| Dec-10-13 | Reiterated | MLV & Co | Buy |
| Dec-10-13 | Upgrade | Needham | Hold → Buy |
| Nov-08-13 | Reiterated | MLV & Co | Buy |
| Oct-16-13 | Initiated | MLV & Co | Buy |
| Aug-30-12 | Initiated | Stifel Nicolaus | Buy |
| Jun-28-12 | Initiated | Needham | Hold |
View All
Geron Corp Stock (GERN) Latest News
Geron Corp stock (US3741631036): Is imetelstat approval the real test for biotech investors now? - AD HOC NEWS
History Review: Can Geron Corporation be the next market leader2026 Key Lessons & Risk Managed Investment Signals - baoquankhu1.vn
GERN Stock Price, Quote & Chart | GERON CORP (NASDAQ:GERN) - ChartMill
Board agenda in new Geron (NASDAQ: GERN) 2026 virtual annual meeting proxy - Stock Titan
Geron Corporation (GERN) stock price, news, quote and history - Yahoo Finance UK
Geron Corporation (GERN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference - The Manila Times
GERN News | GERON CORP (NASDAQ:GERN) - ChartMill
Geron (NASDAQ:GERN) Trading Up 9.7%What's Next? - MarketBeat
Geron Corporation’s Strategic Moves Amplify Stocks in Q1 2026 - StocksToTrade
Market Recap: Can Geron Corporation deliver consistent dividendsPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Geron (NASDAQ:GERN) Share Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Aug Highlights: Can Geron Corporation be the next market leaderExit Point & Breakout Confirmation Trade Signals - baoquankhu1.vn
GERN Technical Analysis | Trend, Signals & Chart Patterns | GERON CORP (NASDAQ:GERN) - ChartMill
Geron Corp Stock: Biotech Investor Focus on RYTELO Commercialization and Valuation Gap Amid Market V - AD HOC NEWS
Geron Adds Biopharma Veterans As RYTELO Focus And Valuation Draw Attention - Yahoo Finance
Assessing Geron (GERN) Valuation After Recent Share Price Weakness - simplywall.st
Geron Corporation Form 8-K Filing Details for March 25, 2026: Company Information, Stock Symbol, and SEC Compliance 16 - Minichart
Vanguard (NASDAQ: GERN) discloses 0 share ownership after realignment - Stock Titan
Geron (NASDAQ: GERN) director granted 270,000 stock options at $1.57 strike - Stock Titan
Geron (GERN) director Constantine Chinoporos files initial Form 3 - stocktitan.net
Geron (GERN) grants director 270,000 stock options at $1.57 - Stock Titan
Geron (GERN) director Patricia Andrews submits initial insider ownership filing - Stock Titan
Geron appoints Patricia S. Andrews and Constantine Chinoporos to board of directors - Investing.com
Geron adds two directors with commercial expertise to board - Investing.com
[8-K] GERON CORP Reports Material Event - Stock Titan
Geron Announces Appointment of New Members to its Board of Directors - ChartMill
Geron Corp stock advances on imetelstat FDA approval momentum and pipeline updates - AD HOC NEWS
Geron's cancer screening patent rejected as non-patentable under Indian law - MLex
Geron (NASDAQ:GERN) Trading Up 8.6%Here's What Happened - MarketBeat
Geron’s Strategic Push: RYTELO’s Rising Global Ambitions - StocksToTrade
GERN SEC FilingsGeron Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Levi & Korsinsky Notifies Shareholders of Geron Corporation(GERN) - The National Law Review
Geron Corporation (NASDAQ:GERN) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Six new Geron hires get stock options on 956,250 shares - Stock Titan
Geron (GERN) reports Q4 loss, misses revenue estimates - MSN
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Details RYTELO Growth Plan, $220M-$240M 2026 Sales Guide and MF Trial Catalyst at Barclays Conference - MarketBeat
Geron (NASDAQ:GERN) Shares Up 8.5%Should You Buy? - MarketBeat
Almitas Capital LLC Buys Shares of 946,323 Geron Corporation $GERN - MarketBeat
Geron (NASDAQ:GERN) Stock Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Geron Corporation (GERN) Reports Q4 EPS of (5c) - Insider Monkey
Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans - Investing.com
How The Geron (GERN) Story Is Shifting After Target Cut And New Equity Plans - Yahoo Finance
11 Fastest Growing Penny Stocks to Buy Right Now - Insider Monkey
Geron Earnings Call: Rytelo Growth Amid Profit Pressures - TipRanks
Geron Empowers Expansion with Rytelo’s Fuel - StocksToTrade
Geron (NASDAQ:GERN) Trading Up 10.9%Here's What Happened - MarketBeat
Geron Corporation $GERN Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Soleus files 5.2% stake in Geron (GERN) via master fund - Stock Titan
A Look At Geron (GERN) Valuation As Investors Weigh RYTELO Growth Against Recent Losses - simplywall.st
Geron Corp Stock (GERN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):